You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KRYS Sale Disclosure
Thomas John Charles · SEC Form 4 · Filed Jun 26, 2026
Sale
Calculated transaction value
$347.27K
Thomas John Charles EVP, General Counsel
KRYS
Krystal Biotech
KRYS
Transaction date
Jun 25, 2026
Public filing date
Jun 26, 2026
Filing lag
Filed 1 day later
KRYS daily price context
Close on/before transaction
$359.93
Jun 25, 2026
First close after public filing
$378.15
Jun 29, 2026
30-day return after filing
-6.96%
Through Jul 27, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,000 shares @ $347.27
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002114900-26-000009
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$526.52K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Krystal Biotech, Inc. KRYS | Exercise | Jun 25, 2026 | $179.25K |
| Krystal Biotech, Inc. KRYS Current | Sale | Jun 25, 2026 | $347.27K |
| Krystal Biotech, Inc. KRYS | Exercise | Jun 25, 2026 | $0 |